Protocol for a feasibility study to inform the development of a multi centre randomised controlled trial of asthma-tailored pulmonary rehabilitation versus usual care for individuals with severe asthma by Majd, S et al.
Protocol for a feasibility study to inform
the development of a multicentre
randomised controlled trial
of asthma-tailored pulmonary
rehabilitation versus usual care
for individuals with severe asthma
Sally Majd,1,2,3 Lindsay D Apps,1,2 Nicky Hudson,4 Stacey Hewitt,1,2
Elizabeth Eglinton,5 Anna Murphy,2,6,7 Peter Bradding,2,3,6 Sally Singh,1,2,3,6
Ruth Green,2,3,6 Rachael Evans1,2,3,6
To cite: Majd S, Apps LD,
Hudson N, et al. Protocol for
a feasibility study to inform





care for individuals with




▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2015-010574).
Received 16 November 2015
Revised 20 December 2015
Accepted 23 December 2015






Introduction: Pulmonary rehabilitation with core
components of exercise training and multiprofessional
education is an integral part of the management of
patients with chronic lung disease. International
guidelines for individuals with asthma recommend
exercise as exercise improves symptoms, indices of
cardiopulmonary efficiency, health status and
psychosocial outcome. However, there is little
published evidence evaluating safety and acceptability
of exercise training for individuals with severe asthma
and there are concerns regarding exercise-induced
asthma. We propose a feasibility study for a
multicentre randomised controlled trial (RCT) of
asthma-tailored pulmonary rehabilitation (asthma-
tailored PR) versus usual care in individuals with
severe asthma.
Methods and analysis: The study will be conducted
in three stages. Adults with severe asthma will be
included if they have persistent symptoms despite
being at step 4 or 5 of the British Thoracic Society
guidelines. Stage 1: semistructured interviews will be
used in a sample of 20–30 individuals with severe
asthma to understand the experience and attitudes of
this population towards exercise. Stage 2: eight focus
groups of at least six healthcare professionals involved
in the care of patients with severe asthma will be
conducted to understand their attitudes towards
exercise for this population. Stage 3: a small-scale
RCT of the proposed multicentre RCT of asthma-
tailored PR versus usual care for individuals with
severe asthma will be conducted. The primary outcome
measures will be recruitment, retention and adverse
event rates. Semistructured interviews with participants
of stage 3 will be used to identify further barriers or
facilitators to participation in PR and the trial. Thematic
analysis will be used for the interpretation of all
interviews.
Ethics and dissemination: The study results will
inform the design of a larger multicentre RCT. The
National Research Ethics Service Committee East
Midland approved the study protocol.
Trial registration number: ISRCTN96143888.
INTRODUCTION
The most recent global estimate of asthma
suggests that up to 334 million people suffer
from asthma with a high burden of disability1
that is estimated to be greater than for both
diabetes and breast cancer.2 Much of this dis-
ability is in the 10–20% of patients with
severe disease despite currently available
therapies3 4 who consume 50–60% of the
healthcare costs attributed to asthma.5 6 This
reflects a considerable unmet need for this
population, and represents a major eco-
nomic burden. Novel approaches to treat-
ment are therefore needed urgently.
Cardiorespiratory fitness is a strong pre-
dictor of mortality in both health and
disease.7 Improving cardiorespiratory fitness
Strengths and limitations of this study
▪ This study focuses on the feasibility of a planned
multicentre randomised controlled trial of
asthma-tailored pulmonary rehabilitation versus
usual care for severe asthma.
▪ The intervention will be tailored using informa-
tion from qualitative studies regarding the views
around exercise and exercise programmes of
both patients with severe asthma and healthcare
professionals involved in their care.
▪ The success of the study will depend on devel-
oping appropriate recruitment strategies.
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through regular exercise reduces the prevalence of
many diseases which are common in patients with severe
asthma8 and importantly reduces the risk of premature
death.9 Unfortunately, asthma has a strong independent
inverse association with cardiorespiratory fitness,10 and
exercise-induced dyspnoea and activity limitation are
very common in patients with asthma11 12 leading to a
fear of exercise.13 A progressive loss of cardiorespiratory
fitness (deconditioning) leads to a reduction in the
threshold for exercise-induced symptoms and a down-
ward spiral of inactivity. Exercise can induce broncho-
constriction in some individuals with asthma, which is
usually a reflection of uncontrolled asthma, but maybe
an overperceived concern for patients and healthcare
professionals alike. In one study, hyperventilation was
the commonest cause of exercise limitation in patients
with difficult asthma, whereas exercise-induced broncho-
constriction was present in <10%.14
Structured physical training is a key component of pul-
monary rehabilitation (PR) programmes (alongside edu-
cation and self-management). PR has shown consistent
benefits for patients with chronic obstructive pulmonary
disease (COPD) and other chronic lung diseases.15 The
principles are to target the extrapulmonary manifesta-
tions including peripheral muscle dysfunction16 and
mood disturbance.15 There are limited data available on
skeletal muscle function in asthma, but the pathological
mechanisms in severe disease maybe similar to those in
patients with COPD, principally inactivity, decondition-
ing, inflammatory and steroid use. A Cochrane review17
concluded that physical training improves cardiorespira-
tory fitness in people with asthma similar to that seen in
non-asthmatic individuals, with no evidence that exercise
had adverse effects on lung function or wheeze however,
the majority of participants were children with
mild-to-moderate asthma. Two studies in adults with
moderate asthma suggested that compared with controls,
supervised exercise training improves symptoms,
health-related quality of life (HRQoL), anxiety and
depression and aerobic capacity.18 19 Unfortunately
similar benefits were not replicated following a 12-week
self-directed exercise programme suggesting that supervi-
sion was a key factor for a positive outcome.20 A further
randomised controlled trial (RCT) reported no adverse
events with exercise training in moderate-to-severe
asthma.21 However, there were limited data regarding the
applicability to adults with severe or refractory asthma as
the majority of study participants had moderate asthma
based on the Global Initiative for Asthma criteria.22
Data from animal models of asthma21 23 suggest that
exercise not only improves cardiorespiratory fitness, but
also directly decreases eosinophilic airway inflammation.
Subsequently, this has been shown in human adults with
moderate-to-severe asthma where a significant reduction
in eosinophilic airway inflammation was seen in those
receiving aerobic training, breathing exercises and edu-
cation compared with a control group receiving breath-
ing exercises and education only.21 A systematic review
on the effect of physical training (moderate-intensity
aerobic exercise) on airway inflammation in adults with
asthma24 suggested physical training may decrease
airway inflammation, but owing to reporting issues, lack
of information and heterogeneity, there was no definite
conclusion.
Obesity is prevalent in people with asthma, which may
contribute to the pathogenesis, and weight loss is asso-
ciated with improved asthma control in this group.25 A
differential effect has been suggested between weight
loss achieved through either diet or exercise on neutro-
philic or eosinophilic airway inflammation, respectively,
in obese individuals with asthma.26
In an earlier study, we surveyed 60 patients with severe
asthma27 and only 25% reported physical activity within
recommended levels, while 65% had stopped exercising
due to asthma symptoms, 87% wanted to be fitter and
72% were interested in participating in an exercise pro-
gramme. Despite this, patients with severe asthma are
often excluded from community-based exercise referral
schemes due to perceived higher risks by providers and
patients, and perhaps some healthcare professionals. For
example, patients with more severe disease are more
likely to believe that exercise is not good for asthma.13
To date, self-directed exercise has been unsuccessful in
this group.20 The UK Department of Health suggests
that patients with severe chronic disease require highly
adapted, supervised exercise programmes.16 All these
factors may cause potential barriers to exercise in
patients with severe asthma.
Standard pulmonary rehabilitation might be beneficial
for this patient population. Previously 111 patients with
a diagnosis of severe asthma completed our local PR
programme designed for patients with COPD.
Statistically significant improvements were seen in dys-
pnoea, anxiety and depression scores, HRQoL and exer-
cise capacity28 (the latter was assessed by the
incremental shuttle walk test (ISWT) also successfully
used for the aerobic training exercise prescription).
Although the results of PR were positive, there was prob-
ably some bias in the referral pattern of our clinicians;
patients were not typical of our severe asthma popula-
tion as they were older with a COPD phenotype.
Importantly, discussions with patients with severe
asthma27 suggest most would prefer to participate in an
exercise programme tailored specifically towards asthma.
Patients would also prefer to exercise near home, but
for safety reasons we initially propose to evaluate a
hospital-based programme. The James Lind Alliance29
has identified physical therapy, psychological interven-
tions and self-management as key areas for research
identified for asthma by patients. We therefore propose
a feasibility study of a RCT of asthma-tailored PR com-
pared with usual care (UC) for individuals with severe
asthma. We will explore both patient and healthcare pro-
fessional attitudes towards exercise in severe asthma.
The data from these studies will be used to inform the
adaptation of current pulmonary rehabilitation for this
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population, and assess the feasibility of a multicentre
trial of asthma-tailored PR for severe asthma.
METHODS AND ANALYSIS
Study design
This feasibility project has been designed using the
Medical Research Council guidelines on developing
complex interventions.30 It will have three stages and
adopts a mixed-methods approach with separate recruit-
ment for each stage.
Participants
Participants for stages 1 and 3 will be recruited from a
population of patients under physicians specialising in
the care of patients with difficult-to-treat asthma at
Glenfield hospital, Leicester, UK, and will have had a
thorough diagnostic assessment and appropriate treat-
ment strategy instituted prior to recruitment. They will
be identified as eligible if they have:
▸ Symptomatic asthma despite being on step 4–5 treat-
ment according to SIGN/BTS guidelines31 (high-dose
inhaled corticosteroids (>1000 µg beclomethasone
equivalent) plus a second controller and/or systemic
corticosteroids);
▸ Been treated under the care of a difficult-to-treat
asthma specialist for at least 6 months.
Participants will be excluded if they:
▸ Have a diagnosis of smoking-related COPD;
▸ Have both fixed airflow obstruction (FEV1/FVC
<70%) and a smoking history of ≥10 pack years;
▸ Are unable to exercise—for example, due to signifi-
cant musculoskeletal or neurological abnormality;
▸ Have a history of significant cardiac disease—for
example, myocardial infarction (MI) within the last
3 months, unstable angina or heart failure, and/or
significant valvular disease;
▸ Had a severe exacerbation of asthma in the preceding
month prior to entry to the programme;
▸ Had a hospital admission due to an exacerbation of
asthma within the last 3 months;
▸ Had an ITU admission involving intubation within
the last year.
Informed written consent from potential participants
will be obtained by the research team.
Stage 1
Understanding the barriers and facilitators to exercise in
individuals with severe asthma
The aims of this qualitative stage are to understand the
experience of individuals with severe asthma and their
attitudes towards physical activity, exercise and structured
exercise programmes. For the current study, the data will
inform:
▸ Approaches to recruitment;
▸ How to overcome the barriers to engaging in exercise
and develop strategies to promote positive exercise
behaviours;
▸ The proposed topics and self-management strategies
for the education component of the PR programme;
▸ Acceptability and therefore feasibility of a structured
programme.
Study design
A descriptive study will be undertaken using semistruc-
tured interviews. Basic demographic information will be
collected and the following patient characteristics to be
represented have been identified (based on previous dis-
cussion with patient representatives, the literature13 32 33
and the research team): age, gender, social class, obesity,
employment status, dependents, living arrangements
and transport availability. Participants will be recruited
until both theoretical saturation and the diversity of the
sample required has been met; a sample of approxi-
mately 20–30 patients is anticipated.
Audio-recorded interviews will be conducted privately
face-to-face between the participant and an interviewer.
Interviews will be transcribed verbatim by a professional
transcriber with identifiable information removed.
Interview questions have been devised based on relevant
literature, experience of the team and consultation with
patient representatives. They will be piloted before use
to ensure validity. Interviews will be analysed using the-
matic analysis34 supported by NVivo software (V.10, QSR
International). This approach follows six distinct stages:
familiarisation with data, generating initial codes,
searching for themes, reviewing themes, defining and
naming themes and producing the report. Initial
coding will be carried out and a sample of interviews
will be coded by a second member of the team to
ensure consistency and to enhance interpretive authen-
ticity. Throughout the data analysis, the team will meet
to discuss and review emerging themes and search for
accounts that provide contesting views of the same phe-
nomena or identify different phenomena. Our patient
representative will be invited to comment on our (anon-
ymised) initial findings to ensure interpretations made
by researchers stay close to the direct experience of
patients.35
Stage 2
Understanding healthcare professionals attitudes towards
exercise as a therapy for severe asthma
The aim of this stage is to explore healthcare profes-
sionals’ perspectives on exercise and exercise pro-
grammes. This data set will be used to inform:
▸ The design of the education for the asthma-tailored
PR programme;
▸ Understand referral behaviours and identify any
potential barriers from healthcare professionals to
promoting exercise;
▸ Recruitment strategies (including information given
to GPs) for the current study and the multicentre
trial;
▸ Dissemination strategies.
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Study design
Eight focus groups of 6–10 healthcare professionals36
involved in the care of patients with severe asthma will
be conducted. A purposive sampling strategy will be
employed to ensure a range of professions and seniority
is represented including physiotherapists, asthma nurses,
pharmacists, respiratory nurses, general respiratory phy-
sicians, occupational therapists, general practitioners
(GPs) and managers. Personnel will be recruited from a
tertiary referral centre (n=1), district general hospitals
(n=3) and local GP practices (n=4) to fully explore views
across different settings. The focus groups will be held
in the respective settings to maximise participation.
Group discussions will be facilitated by a researcher
experienced in qualitative research and will encourage
the exchange of consensus and disagreements on par-
ticipation in exercise and exercise programme for this
population.
Focus groups will be audio-recorded and transcribed
as per stage 1. Methodology for data analysis will be as
described for stage 1, but will pay close attention to the
additional complexity and interaction inherent in focus
group data.37 A sample of transcripts will be analysed by
all members of the research team to ensure agreement
over emerging themes.
Stage 3
A small-scale version of an RCT trial of asthma-tailored PR
versus UC in individuals with severe asthma
Study design
A small-scale RCT will be conducted to assess feasibility
of a large multicentre trial. A maximum of 60 patients
will be recruited. Participants will be randomised to
either the asthma-tailored PR group or UC group using
internet-based ‘sealed envelope’ randomisation codes as
advised by our local clinical trials unit. Randomisation to
treatment group allocation will be a 2:1 ratio (asthma-
tailored PR:UC) as retention rate is the primary
outcome rather than effectiveness. Randomisation allo-
cation is sent by automated email to unblinded research
team members (data will be collected and analysed
prior and immediately post intervention and at 6-month
follow-up (figure 1)).
Intervention (asthma-tailored PR)
Asthma-tailored PR will be based on a traditional PR
programme but will be exclusively for severe asthma. It
will be undertaken in a hospital setting in case of
adverse events. The programme will extend over
12 weeks with two supervised, 2 h sessions per week (1 h
of exercise and 1 h of multidisciplinary education) and a
well-defined home exercise programme. A rolling pro-
gramme will be used and the duration of the pro-
gramme may have to be extended for return after
exacerbations.
For the exercise component, combined endurance
and strength training will be based on our local success-
ful PR programme and evidence-based international
guidelines for PR and health.38 39 An exercise prescrip-
tion includes intensity, frequency, mode and duration,
but there is little specific guidance for asthma38 40 other
than high-intensity aerobic training41 (60–80% of peak
oxygen consumption (VO2 peak) or peak heart rate).
We propose predominantly high-intensity walking-based
endurance training, as our local preliminary data were
successful.28 We will aim for an initial walking duration
between 6 and 10 min to be increased to 20–30 min over
1–4 weeks aiming for an end Borg Score for breathless-
ness of 4–6.42 The speed of the walk will be recalibrated
at 4 and 8 weeks, where needed. It is anticipated that
fast walking will be high-intensity exercise for this popu-
lation, but cycling or jogging will be prescribed if
needed. A home walking diary will be kept and partici-
pants advised to walk daily. Strength training will com-
prise upper and lower limb exercises: two sets of 6–12
repetitions at 80% one repetition maximum for knee
extensors and flexors on the gym equipment and elbow
flexion and extension using free weights. The pro-
gramme above is a preliminary design and any part of
this will be adapted for the feasibility study according to
the results of stages 1 and 2.
Half of the educational component will comprise a
series of sessions facilitated by the multidisciplinary
team. These will be based on the current PR education
programme but will be developed to be more specific to
Figure 1 Study timetable.
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patients with asthma. There will be some modification
after stages 1 and 2 regarding the topics and content of
the sessions. The other half of the education sessions
will be based on motivational consultation delivered by a
health psychologist and related to discussion within the
group about modifying behaviour, how to become more
active, exercise diary review, setting and resetting goals.
Usual care
All participants will be seen by physicians specialising in
the care of patients with difficult-to-treat asthma. They
will receive standard asthma management including
disease education provided by experienced asthma
nurse specialists; specific advice regarding participation
in regular exercise will be given. They will be offered
standard PR after participation in the trial.
Outcome measurements
The primary outcome measures are:
▸ Recruitment rate (incorporating willingness of
patients to be randomised and practicality of a
hospital-based programme);
▸ Retention rate (incorporating acceptability of the
therapy);
▸ Incidence of adverse events.
We will record the time to recruit and complete the
trial.
The secondary outcome measures are:
▸ Exercise capacity assessed by both laboratory tread-
mill testing (and optional cycle ergometer),43
(including exercise-induced bronchoconstriction44
and dynamic hyperinflation) and field testing by both
ISWT45 and the endurance shuttle walk test
(ESWT).46 The repeatability of the ISWT in this
population will also be assessed.
▸ Sputum eosinophil count,47 exhaled nitric oxide and
inflammatory markers in the blood.
▸ Asthma control using the Asthma Control
Questionnaire (ACQ).48
▸ HRQoL using the Asthma Quality of Life
Questionnaire (AQLQ)49–51 and Chronic Respiratory
Questionnaire.52
▸ Psychological morbidity using the Hospital Anxiety
and Depression Scale.48
▸ Quadriceps strength assessed by an adapted chair
with a strain gauge53 and body composition assessed
by dual-energy X-ray absorptiometry (DEXA).53
▸ Domestic physical activity measured by tri-axial accel-
erometers (Sensewear pro 3).52
The outcome measures to assess the intervention will
be collected at baseline, 12 weeks and 9 months by a
blinded investigator (see figure 1 for study schedule).
Baseline demographics will be recorded including body
mass index (BMI) and spirometry. To promote partici-
pant retention and follow-up, all the study visit dates and
times will be arranged at the participant’s convenience
during the first visit. They will receive a reminder tele-
phone call the day before their visit. In the event of
participant’s withdrawal, any data collected prior to that
point will be reported.
Safety
▸ Any adverse events directly or indirectly related to the
exercise measurements and training sessions will be
recorded. Any severe adverse event will be reported
to our research and development office immediately.
An external respiratory physician has agreed to inde-
pendently assess any adverse events and stop the trial,
if necessary
▸ A full cardiopulmonary exercise test with expiratory
gas analysis will be performed on a treadmill.43
Exercise-induced bronchoconstriction will be assessed
by a flow-volume loop, before and after the treadmill
test. This data will be used as an outcome measure
not just for safety
▸ Asthma control and disease activity will be assessed by
the ACQ, measuring airway inflammation by induced
sputum count before and after the intervention and
by comparing the preceding 9 months unscheduled
healthcare visits for asthma with 9 months after and
including the intervention including GP, accident
and emergency attendance and hospital admissions
Cost-effectiveness
The EuroQol54 questionnaire will be used to assess
quality-adjusted life-years (QALYs) at baseline, 12 weeks
and 9 months. Costs will be calculated using NHS tariffs.
All treatment including medication, adverse events and
any over-the-counter medication will be recorded.
Exacerbation of asthma
Patients will be asked to keep a diary of their exacerba-
tions, treatment and unscheduled healthcare visits. The
patients will be asked to stop coming to the asthma-
tailored PR sessions for any exacerbation requiring
steroid treatment. If they are not recovered enough to
start participation within 2 weeks, they will be classified
as dropout. Similarly, they will be excluded from the UC
limb if they are not back to normal within 2 weeks to
avoid bias.
Sample size calculation
The primary outcomes for the feasibility study are
recruitment, retention and incidence of adverse events,
to establish the practicality of a definitive multicentre
RCT. We plan to recruit 40 patients to the intervention
arm and 20 patients to UC. We estimate conservatively
that we will recruit 30% of those invited to estimate the
recruitment rate with a precision of at least ±7%. We
suggest a conservative dropout rate of 25% (our local PR
dropout rate is approximately 15%); recruiting 40
patients to the asthma-tailored PR programme, the pre-
cision of the estimated retention rate would be at least
±14%.55 From experience to date, we are expecting very
few serious adverse events relating to the exercise pro-
gramme. Based on a rate of 2.5%, the rate would be
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estimated to be less than 13%.56 All precisions are based
on two-sided 95% CIs.
Statistical analysis
Data collected will be entered to a secured local data-
base by the researchers. A descriptive analysis will be
performed using mean (SD) and median (IQR) for nor-
mally and not normally distributed variables, respect-




We have organised a steering group consisting of an
external investigator, patient representatives, statistician
and the coinvestigators of the project who will meet
three times a year to review the safety and progress of
the project.
The principle and coinvestigators will have access to
the local data set with password-protected access.
Dissemination
The results of this feasibility study will inform the plan-
ning of a definitive RCT, including whether it can be
done, by assessing rates of recruitment, retention,
serious adverse events and data collection. The qualita-
tive and physiological analysis will be used to further
refine the asthma-tailored PR programme and the study
protocol for the proposed multicentre trial. The partici-
pants will be encouraged to have a role in the design of
the definitive trial. The findings of the study and the
subsequent proposal for the multicentre RCT will be
presented to potential collaborators including British
Thoracic Society Severe Asthma registry along with local
GPs, respiratory nurse specialists and medical colleagues
through presentations at local educational events. We
will also disseminate the findings of the feasibility study
and the proposed RCT to the charity Asthma UK and to
our local asthma and pulmonary rehabilitation PPI
advisory groups before seeking funding for the substan-
tive multicentre study from the HTA or Asthma UK. The
results of the feasibility study (stages 1–3) will be pre-
sented at local, national and international respiratory
meetings as well as in manuscripts submitted to peer-
reviewed journals.
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